Combination detection of serum squamous cell carcinoma antigen and carcino-embryonic antigen for the diagnosis of cervical carcinoma and evaluation of effect
10.3760/cma.j.issn.1006-9801.2016.08.003
- VernacularTitle:血清鳞状细胞癌抗原和癌胚抗原联合检测对子宫颈癌的诊断及疗效评价
- Author:
Tong CUI
;
Cunzhi HAN
- Publication Type:Journal Article
- Keywords:
Uterine cervical neoplasms;
Tumor markers,biological;
Diagnosis;
Treatment outcome
- From:
Cancer Research and Clinic
2016;28(8):513-518
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical significance of combination detection of serum squamous cell carcinoma antigen (SCC-Ag) and carcino-embryonic antigen (CEA) for the diagnosis,effect evaluation,monitoring and prognosis in cervical carcinoma.Methods Four hundred and twenty-four cases of cervical carcinoma patients diagnosed by pathology and 400 binign gynaecology patients were selected to detect levels of SCC-Ag and CEA by ELISA.Besides,the pelvic color ultrasound results of cervical carcinoma patients were collected and analyzed.Results The positive rates of serum SCC-Ag,CEA and combined detection of cervical carcinoma patients were 55.9 %(237/424),26.4 %(112/424),61.8 %(262/424),which were higher than those of binign gynaecology patients [12.0 %(48/400),12.5 %(50/400),14.5 %(58/400)],and the differences were statistical significance (all P< 0.05).The sensitivity of combined detection of SCC-Ag and CEA for diagnosing cervical carcinoma (61.8 %) was better than that of detection of alone SCC-Ag or CEA (55.9 %,26.4 %),and the difference was statistical significance (P < 0.05).The differences of pretreatment serum SCC-Ag and CEA levels in the cervical carcinoma patients who were dependent on clinical stage,pathological type,depth of invasion,lymph node metastasis were statistically significant (all P < 0.05).The combined detection of SCC-Ag and CEA in patients with stage Ⅰ and Ⅱ had higher positive rates [45.5 % (71/156),73.2 %(139/190)] than those of the ultrasound examination [33.3 %(52/156),51.1%(97/150)] (P< 0.05).After surgery or concurrent chemoradiotherapy or surgery combined radiation and chemotherapy,SCCAg levels of patients in post-treatment (median 0.34,0.51,0.33 ng/ml) were much lower than those of pretreatment (median 0.48,3.44,1.29 ng/ml),and CEA levels of post-treatment (median 0.75,0.81,0.71 ng/ml)were also lower than those of pre-treatment (median 1.22,1.53,1.50 ng/ml) (P < 0.05).After treatment,cervical cancer patients with the raised or not decreased to the normal range levels of SCC-Ag and CEA had recurrences or metastasis rates of 33.3 %(6/18),56.5 %(13/23) and 46.1%(35/76).Survival rate of the patients with positive SCC-Ag was significantly lower than that of patients with negative (P < 0.05),while the survival rate of patients with positive or negative CEA had no difference (P > 0.05).Conclusions Combined detection of SCC-Ag and CEA can be used as an important indicator to estimate clinical stage,pathological type,depth of invasion,lymph node metastasis,curative effect and prognosis of cervical carcinoma.Combined detection of SCC-Ag and CEA had higher positive rates than pelvic color ultrasound examination for cervical carcinoma patients in stage Ⅰ and Ⅱ.